Soo Fong Lee

US Patent:

6346605, Feb 12, 2002

Filed:

Mar 31, 1998

Appl. No.:

09/052089

Inventors:

Soo Young Lee - New York NY
Yongwon Choi - New York NY

Assignee:

The Rockfeller University - New York NY

International Classification:

C07K 1447

US Classification:

530350, 530351, 514 2

Abstract:

A novel component of the TRAF (TNF Receptor Associated Factor) signaling complex, designated TRIP (TRAF Interacting Protein) which associates with the TNFR2 or CD30 signaling complex through its interaction with the TRAF2 protein and influences signals responsible for cell activation, cell proliferation and cell death.

US Patent:

6900050, May 31, 2005

Filed:

Nov 20, 2000

Appl. No.:

09/716536

Inventors:

Soo Young Lee - New York NY, US
Yongwon Choi - New York NY, US

Assignee:

The Rockefeller University - New York NY

International Classification:

C12N015/12
C12N005/10

US Classification:

4353201, 435325, 536 235

Abstract:

A novel component of the TRAF (TNF Receptor Associated Factor) signaling complex, designated TRIP (TRAF Interacting Protein) which associates with the TNFR2 or CD30 signaling complex through its interaction with the TRAF2 protein and influences signals responsible for cell activation, cell proliferation and cell death.

US Patent:

7378492, May 27, 2008

Filed:

Feb 18, 2003

Appl. No.:

10/504973

Inventors:

Narinder K. Chawla - Union City CA, US
Henry Yue - Sunnyvale CA, US
Thomas W. Richardson - Redwood City CA, US
Joseph P. Marquis - San Jose CA, US
Ann E. Gorvad - Livermore CA, US
Shanya D. Becha - Castro Valley CA, US
Amy E. Kable - San Francisco CA, US
Anita Swarnakar - San Francisco CA, US
Pei Jin - Palo Alto CA, US
Phillip R. Hawkins - Mountain View CA, US
David Chien - Los Altos CA, US
Jayalaxmi Ramkumar - Freemont CA, US
Uyen K. Tran - San Jose CA, US
April J. A. Hafalia - Santa Clara CA, US
Mariah R. Baughn - San Leandro CA, US
Soo Yeun Lee - Daly City CA, US
Xin Jiang - Saratoga CA, US
Alan A. Jackson - Los Gatos CA, US
Reena Khare - Saratoga CA, US
Sean A. Bulloch - Cupertino CA, US

Assignee:

Incyte Corporation - Wilmington DE

International Classification:

C07K 14/705
C07K 19/00

US Classification:

530350, 435 691, 435 697, 536 234, 536 235

Abstract:

Various embodiments of the invention provide human receptors and membrane-associated proteins (REMAP) and Q polynucleotides which identify and encode REMAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of REMAP.

US Patent:

20030198975, Oct 23, 2003

Filed:

Oct 31, 2002

Appl. No.:

10/287218

Inventors:

Yalda Azimzai - Oakland CA, US
Janice Au-Young - Brisbane CA, US
Sajeev Batra - Oakland CA, US
Mariah Baughn - San Leandro CA, US
Shanya Becha - Castro Valley CA, US
Mark Borowsky - Redwood City CA, US
Neil Burford - Durham CT, US
Li Ding - Creve Coeur MO, US
Vicki Elliott - San Jose CA, US
Brooke Emerling - Chicago IL, US
Ameena Gandhi - San Francisco CA, US
Kimberly Gietzen - San Jose CA, US
Jennifer Griffin - San Jose CA, US
April Hafalia - Santa Clara CA, US
Cynthia Honchell - San Carlos CA, US
Preeti Lal - Santa Clara CA, US
Soo Lee - Daly City CA, US
Dyung Aina Lu - San Jose CA, US
Chandra Arvizu - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Roopa Reddy - Sunnyvale CA, US
Madhusudan Sanjanwala - Los Altos CA, US
Y. Tom Tang - San Jose CA, US
Narinder Chawla - Union City CA, US
Yu-Mei Wang - Mountain View CA, US
Bridget Warren - Encinitas CA, US
Yuming Xu - Mountain View CA, US
Junming Yang - San Jose CA, US
Monique Yao - Carmel IN, US
Henry Yue - Sunnyvale CA, US
Yeganeh Zebarjadian - San Francisco CA, US

Assignee:

Incyte Genomics, Inc. - Palo Alto CA

International Classification:

C12Q001/68
C07H021/04
C12N009/00
C12P021/02
C12N005/06
C07K014/47
A61K048/00

US Classification:

435/006000, 435/069100, 435/183000, 435/320100, 435/325000, 530/350000, 536/023200, 530/388260, 514/044000

Abstract:

The invention provides human proteins associated with cell growth, differentiation, and death (CGDD) and polynucleotides which identify and encode CGDD. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CGDD.

US Patent:

20040110180, Jun 10, 2004

Filed:

Oct 1, 2003

Appl. No.:

10/473670

Inventors:

Shirley Recipon - San Francisco CA, US
John Burrill - Redwood City CA, US
Gregory Marcus - San Carlos CA, US
Kurt Zingler - San Francisco CA, US
Y Tang - San Jose CA, US
Michael Thornton - Oakland CA, US
Mark Borowsky - Northampton MA, US
Mariah Baughn - Los Angeles CA, US
Neil Burford - Durham CT, US
Soo Lee - Daly City CA, US
Olga Bandman - Mountain View CA, US
April Hafalia - Daly City CA, US
Monique Yao - Mountain View CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Narinder Chawla - Union City CA, US
Dyung Aina Lu - San Jose CA, US
Chandra Arvizu - San Diego CA, US
Ison Craig - San Jose CA, US
Li Ding - Creve Coeur MO, US
Yan Lu - Mountain View CA, US
Rajagopal Gururajan - San Jose CA, US
Roderick Walsh - Sandwich, GB
Ameena Gandhi - San Francisco CA, US
Anita Swarnakar - San Francisco CA, US
Ian Forsythe - Edmonton CA, US
Henry Yue - Sunnyvale CA, US
Janice Au-Young - Brisbane CA, US
Vicki Elliott - San Jose CA, US
Sally Lee - San Francisco CA, US

International Classification:

C12Q001/68
C07H021/04
C12N009/12
C12N009/16

US Classification:

435/006000, 435/069100, 435/194000, 435/196000, 435/320100, 435/325000, 536/023200

Abstract:

The invention provides human kinases and phosphatases (KPP) and polynucleotides which identify and encode KPP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.

US Patent:

20040132043, Jul 8, 2004

Filed:

Oct 6, 2003

Appl. No.:

10/474291

Inventors:

Yalda Azimzai - Oakland CA, US
Janice Au-Young - Brisbane CA, US
Sajeev Batra - Oakland CA, US
Mariah Baughn - Los Angeles CA, US
Shanya Becha - San Francisco CA, US
Mark Borowsky - Northampton MA, US
Neil Burford - Durham CT, US
Li Ding - Creve Couer MO, US
Vicki Elliott - San Jose CA, US
Brooke Emerling - Chicago IL, US
Ameena Gandhi - San Francisco CA, US
Kimberly Gietzen - San Jose CA, US
Jennifer Griffin - Fremont CA, US
April Hafalia - Daly City CA, US
Cynthia Honchell - San Carlos CA, US
Preeti Lal - Santa Clara CA, US
Soo Lee - Mountain View CA, US
Dyung Aina Lu - San Jose CA, US
Chandra Arvizu - San Diego CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Roopa Reddy - Fremont CA, US
Madhusudan Sanjanwala - Los Altos CA, US
Y Tang - San Jose CA, US
Narinder Chawla - Union City CA, US
Yu-Mei Wang - Mountain View CA, US
Bridget Warren - San Marcos CA, US
Yuming Xu - Mountain View CA, US
Junming Yang - Sa Jose CA, US
Monique Yao - Mountain View CA, US
Henry Yue - Sunnyvale CA, US
Yeganeh Zebarjadian - San Francisco CA, US

International Classification:

C12Q001/68
C07H021/04
C07K014/47
C12N015/00

US Classification:

435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 536/023500

Abstract:

The invention provides human proteins associated with cell growth, differentiation, and death (CGDD) and polynucleotides which identify and encode CGDD. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CGDD.

US Patent:

20040203014, Oct 14, 2004

Filed:

Mar 12, 2004

Appl. No.:

10/489372

Inventors:

Cynthia Honchell - San Francisco CA, US
Bridget Warren - San Marcos CA, US
Mark Borowsky - Needham MA, US
Jennifer Griffin - Fremont CA, US
Joana Li - Millbrae CA, US
Soo Lee - Mountain View CA, US
Henry Yue - Sunnyvale CA, US
Ian Forsythe - Edmonton, CA
Joseph Marquis - San Jose CA, US
Kimberly Gietzen - San Jose CA, US
Mariah Baughn - Los Angeles CA, US
Uyen Tran - San Jose CA, US
Y. Tang - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Brooke Emerling - Chicago IL, US
Ernestine Lee - Kensington CA, US
Vicki Elliott - San Jose CA, US
April Hafalia - Daly City CA, US
Brendan Duggan - Sunnyvale CA, US
Narinder Chawla - Union City CA, US
Amy Kable - Silver Spring MD, US
Hsin-Ru Chang - Belmont CA, US
Reena Khare - Saratoga CA, US
Shanya Becha - San Francisco CA, US
Pei Jin - Palo Alto CA, US
Sally Lee - San Jose CA, US

International Classification:

C12Q001/68
C07H021/04
C12N015/00
C07K014/705

US Classification:

435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 536/023500

Abstract:

Various embodiments of the invention provide human neurotransmission-associated proteins (NTRAN) and polynucleotides which identify and encode NTRAN. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NTRAN.

US Patent:

20050019763, Jan 27, 2005

Filed:

Apr 5, 2002

Appl. No.:

10/473451

Inventors:

Ameena Gandhi - San Francisco CA, US
Angelo Delegeane - Milpitas CA, US
Anita Swarnakar - San Francisco CA, US
April Hafalia - Daly City CA, US
Brendan Duggan - Sunnyvale CA, US
Bridget Warren - San Marcos CA, US
Brooke Emerling - Chicago IL, US
Chandra Arvizu - San Diego CA, US
Cynthia Honchell - San Carlos CA, US
Deborah Kallick - Galveston TX, US
Dyung Lu - San Jose CA, US
Ernestine Lee - Kensington CA, US
Henry Yue - Sunnyvale CA, US
Ian Forsythe - Edmonton, CA
Jayalaxmi Ramkumar - Fremont CA, US
Jennifer Griffin - Fremont CA, US
Joana Li - Millbrae CA, US
Kavitha Thangavelu - Sunnvyale CA, US
Mariah Baughn - Los Angeles CA, US
Monique Yao - Mountain View CA, US
Madhusudan Sanjanwala - Los Altos CA, US
Narinder Chawla - Union City CA, US
Neil Burford - Durham CT, US
Preeti Lal - Santa Clara CA, US
Shanya Becha - San Francisco CA, US
Soo Lee - Mountain View CA, US
Vicki Elliott - San Jose CA, US
Wen Luo - San Diego CA, US
Yan Lu - Mountain View CA, US
Yu-mei Wang - Mountain View CA, US

International Classification:

C12Q001/68
A01K067/00
C07H021/04
C12N009/64

US Classification:

435006000, 435069100, 435226000, 435320100, 435325000, 536023200, 800008000

Abstract:

The invention provides human protein modification and maintenance molecules (PMOD) and polynucleotides which identify and encode PMOD. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PMOD.